To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill requires currently accepted medical use with severe restrictions Section 102 of the Controlled Substances Act (21 U.S.C. It relies on definition changes, compliance mandates, exemptions, and delegation of rulemaking. The main policy areas are Healthcare Consumers, Housing, and Healthcare.
Who Benefits and How
Patients and health care consumers affected by the bill could face lower compliance burdens and Homeowners, tenants, or housing market participants affected by the bill could face lower compliance burdens.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties and Public beneficiaries or protected communities affected by the clause could face increased risk.
Key Provisions
- Requires currently accepted medical use with severe restrictions Section 102 of the Controlled Substances Act (21 U.S.C.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill requires currently accepted medical use with severe restrictions Section 102 of the Controlled Substances Act (21 U.S.C.
Key Policy Areas
Healthcare Consumers, Housing, Healthcare
Primary Purpose
The bill requires currently accepted medical use with severe restrictions Section 102 of the Controlled Substances Act (21 U.S.C.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Public beneficiaries or protected communities affected by the clause
Sponsors
Madeleine Dean
D-PA | Primary Sponsor
Legislative Progress
IntroducedMs. Dean of Pennsylvania (for herself and Ms. Mace) introduced …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology